// App-Quantinova.ai

10066 : Physiological Levels of PCSK9 Promote Hepatic and Intestinal Overproduction of Apolipoprotein-B Lipoproteins through LDL-Receptor Dependent and Independent Mechanisms

Researchers

Presenter

  • Hagai Tavori

Principal Investigators

  • Ilaria Giunzioni

  • Harry R Davis

  • David R Neff

  • Sergio Fazio

Medical Centers

  • Vanderbilt University, Nashville, TN

  • McMaster University, Hamilton, ON, Canada

Locations

  • United States

  • Canada

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Dyslipidemia

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved